RAC1 is listed as a significant member of the Rho GTPases, which are involved in the tumor cell cycle, invasion, proliferation, apoptosis, angiogenesis, and migration, and are viewed as promising targets for preventing and treating cancers (Liang et al. 2021). Here, RAC1 is linked to neoplasm.